Term
|
Definition
Entecavir (Baraclude®)
Lamivudine (Epivir®)
Telbivudine (Tyzeka®)
Tenofovir (Viread®) |
|
|
Term
|
Definition
Baraclude®
MOA: Inhibits reverse transcriptase; incorporates into viral DNA
NRTI |
|
|
Term
|
Definition
Epivir®
MOA: Inhibits reverse transcriptase; incorporates into viral DNA
NRTI |
|
|
Term
|
Definition
Tyzeka®
MOA: Inhibits reverse transcriptase; incorporates into viral DNA
NRTI |
|
|
Term
|
Definition
Viread®
MOA: Inhibits reverse transcriptase; incorporates into viral DNA
NRTI |
|
|
Term
|
Definition
Peginterferon alfa-2a (Pegasys®)
Peginterferon alfa-2b (PEG-Intron®)
MOA: Inhibits viral replication; various antiviral, antiproliferative, and immunomodulatory effects
Used in both Hepatitis B and Hepatitis C |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
Ribavirin (Copegus®)
Used in combination with interferons |
|
|
Term
|
Definition
Copegus®, Rebetol®
MOA: Inhibits replication of RNA and DNA viruses; Inhibits influenza virus RNA polymerase activity and inhibits the initiation and elongation of RNA fragments resulting in inhibition of viral protein synthesis
Antiviral Agent |
|
|
